CREAMMIST is an integrated cancer drug sensitivity database for in vitro pharmacogenomics analysis, providing an integrative dose-response curve across five widely used cancer cell-line drug-response
A COMPARE analysis was performed by correlating protein levels of CDK1 activating machinery components with GI50 (concentration producing 50% growth inhibition) values of chemotherapeutic agents in NC
